NDC codes

415010 NDC codes with hospital pricing data in the network.

• NDC 00641-6028-25 — Fentanyl injection, 50 mcg per mLAI (254 hospitals, 31,159–36,073 samples)
• NDC 48783-0112-08 — FERRIC SUBSULFATE PASTEAI (792 hospitals, 34,933–36,058 samples)
• NDC 24208-0785-55 — Neomycin, bacitracin, polymyxin and hydrocortisone ointment tubeAI (655 hospitals, 34,995–36,057 samples)
• NDC 00597-0197-05 — Idarucizumab intravenous solution, 2.5 g per 50 mLAI (945 hospitals, 34,477–36,043 samples)
• NDC 00409-4283-11 — Lidocaine 4% local anesthetic injection, preservative-freeAI (432 hospitals, 30,865–36,040 samples)
• NDC 69488-0001-40 — Gallium Ga-68 dotatate injection kitAI (358 hospitals, 35,308–36,028 samples)
• NDC 00093-3426-01 — LORazepam 1 mg tabletAI (572 hospitals, 35,056–36,001 samples)
• NDC 55150-0237-01 — Dexamethasone 4 mg/mL injectionAI (300 hospitals, 31,327–35,980 samples)
• NDC 00603-1880-10 — Lidocaine 5% patchAI (265 hospitals, 34,852–35,959 samples)
• NDC 67877-0251-15 — Triamcinolone 0.1% creamAI (635 hospitals, 34,742–35,957 samples)
• NDC 50383-0267-15 — CLOBETASOL 0.05 % TOPICAL CREAMAI (120 hospitals, 34,983–35,928 samples)
• NDC 82584-0792-01 — Lidocaine 3.5% topical gelAI (325 hospitals, 34,931–35,921 samples)
• NDC 00143-9785-01 — Valproate sodium injection, 100 mg/mLAI (498 hospitals, 34,749–35,910 samples)
• NDC 45802-0098-51 — Mesalamine enema, 60 mL bottleAI (693 hospitals, 34,814–35,867 samples)
• NDC 00168-0357-05 — Lidocaine-prilocaine numbing cream 2.5%AI (322 hospitals, 34,763–35,789 samples)
• NDC 66658-0234-07 — Anakinra 100 mg prefilled syringeAI (511 hospitals, 34,690–35,788 samples)
• NDC 65162-0833-66 — Diclofenac Sodium 1 % Gel 100 g TUBEAI (263 hospitals, 34,710–35,772 samples)
• NDC 00591-3508-04 — Clonidine 0.1 mg/24-hour transdermal patchAI (347 hospitals, 34,617–35,769 samples)
• NDC 00409-7983-09 — Sodium chloride 0.9% IV solutionAI (190 hospitals, 33,202–35,749 samples)
• NDC 45802-0580-01 — Scopolamine patch, 1 mg over 3 daysAI (504 hospitals, 34,604–35,720 samples)
• NDC 60505-6148-00 — Ceftriaxone 1 gram injectionAI (487 hospitals, 20,294–35,702 samples)
• NDC 72485-0625-13 — Ciprofloxacin and dexamethasone ear dropsAI (450 hospitals, 34,358–35,699 samples)
• NDC 45802-0059-35 — Nystatin 100,000 unit/g topical creamAI (940 hospitals, 34,400–35,696 samples)
• NDC 70860-0784-05 — Valproate sodium 500 mg/5 mL IV injectionAI (217 hospitals, 34,579–35,695 samples)
• NDC 00409-2308-22 — Midazolam 5 mg/mL nasal sprayAI (338 hospitals, 30,365–35,630 samples)
• NDC 00904-6551-61 — Ondansetron 4 mg oral tabletsAI (372 hospitals, 26,784–35,613 samples)
• NDC 00121-4577-40 — Lactulose 10 g/15 mL oral solutionAI (144 hospitals, 34,609–35,608 samples)
• NDC 00574-2008-30 — Nystatin topical powderAI (252 hospitals, 34,611–35,601 samples)
• NDC 00037-6822-10 — Proctofoam HC 1% rectal foamAI (591 hospitals, 34,577–35,531 samples)
• NDC 00904-6351-61 — Levofloxacin 250 mg tabletsAI (876 hospitals, 34,550–35,531 samples)
• NDC 65282-1605-01 — Lidocaine 1% injectable solutionAI (336 hospitals, 30,426–35,529 samples)
• NDC 60219-1749-03 — Atropine sulfate 1% eye dropsAI (642 hospitals, 33,545–35,516 samples)
• NDC 69315-0904-01 — Lorazepam 0.5 mg tabletAI (865 hospitals, 33,963–35,475 samples)
• NDC 63323-0286-95 — Ropivacaine 0.5% injection, 30 mLAI (268 hospitals, 34,896–35,445 samples)
• NDC 00713-0503-06 — Hydrocortisone 25 mg rectal suppositoryAI (492 hospitals, 34,497–35,442 samples)
• NDC 17238-0424-25 — Indocyanine green injection, 25 mg vialAI (93 hospitals, 34,786–35,434 samples)
• NDC 62332-0655-01 — Formoterol nebulizer solution 20 mcg per 2 mLAI (74 hospitals, 34,470–35,424 samples)
• NDC 69547-0627-02 — Naloxone 4 mg nasal sprayAI (240 hospitals, 34,319–35,372 samples)
• NDC 13925-0522-01 — Pentamidine isethionate 300 mg injection solutionAI (466 hospitals, 33,710–35,339 samples)
• NDC 00409-9093-35 — Fentanyl injection, 50 mcg per mLAI (341 hospitals, 33,150–35,337 samples)
• NDC 68462-0756-01 — Ketorolac 30 mg/mL injection solutionAI (199 hospitals, 32,332–35,311 samples)
• NDC 00713-0503-24 — Hydrocortisone 25 mg rectal suppositoryAI (283 hospitals, 34,210–35,308 samples)
• NDC 45802-0269-37 — Permethrin 5% cream, 60 g tubeAI (656 hospitals, 34,205–35,258 samples)
• NDC 70004-0430-12 — Ketamine 100 mg/10 mL syringe for IV useAI (45 hospitals, 34,330–35,257 samples)
• NDC 00071-0418-13 — nitroglycerin 0.4 mg sublingual tabletAI (519 hospitals, 34,476–35,250 samples)
• NDC 70756-0606-85 — VERAPAMIL 10 MG/4 ML VIALAI (51 hospitals, 35,122–35,248 samples)
• NDC 70756-0606-05 — VERAPAMIL 10 MG/4 ML VIALAI (75 hospitals, 35,122–35,248 samples)
• NDC 67877-0124-20 — Silver sulfadiazine 1% topical creamAI (451 hospitals, 34,242–35,241 samples)
• NDC 00115-1687-74 — Budesonide inhalation suspension 0.25 mg per 2 mLAI (111 hospitals, 35,101–35,200 samples)
• NDC 00115-1687-76 — Budesonide inhalation suspension for nebulizerAI (83 hospitals, 35,100–35,190 samples)